KOSDAQ - Delayed Quote KRW

HLB Co., Ltd. (028300.KQ)

57,800.00
+800.00
+(1.40%)
At close: May 9 at 3:30:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
68,125,727.34
68,125,727.34
42,900,561.19
179,707,913.11
69,825,991.45
Cost of Revenue
56,071,158.76
56,071,158.76
43,794,069.45
113,463,198.73
48,758,568.42
Gross Profit
12,054,568.58
12,054,568.58
-893,508.26
66,244,714.38
21,067,423.03
Operating Expense
130,420,722
130,420,722
115,061,731
140,908,110
120,881,488
Operating Income
-118,366,153.42
-118,366,153.42
-115,955,239.26
-74,663,395.62
-99,814,064.97
Net Non Operating Interest Income Expense
-7,534,026.11
-7,534,026.11
-3,938,784.30
-9,952,678.77
-2,263,104.05
Pretax Income
-109,249,140.85
-109,249,140.85
-212,796,314.22
-88,410,733.06
-110,449,430.20
Tax Provision
-1,222,342.29
-1,222,342.29
-10,493,054.87
10,192,611.27
1,157,395.74
Net Income Common Stockholders
-91,980,166.74
-91,980,166.74
-187,546,646.85
-78,158,868.86
-98,125,465.67
Basic EPS
-704.00
--
-1.55k
-640.00
-816.08
Diluted EPS
-704.00
--
-1.55k
-640.00
-816.08
Basic Average Shares
130,653.65
--
121,232.48
122,123.23
120,240.50
Diluted Average Shares
130,653.65
--
121,232.48
122,123.23
120,240.50
Total Operating Income as Reported
-118,516,152.92
-118,516,152.92
-125,024,740.61
-74,664,893.05
-101,018,424.28
Rent Expense Supplemental
777,309
777,309
558,883
696,633
472,933
Total Expenses
186,491,880.76
186,491,880.76
158,855,800.45
254,371,308.73
169,640,056.42
Net Income from Continuing & Discontinued Operation
-91,980,166.74
-91,980,166.74
-187,546,646.85
-78,158,868.86
-98,125,465.67
Normalized Income
-113,584,552.30
-113,584,552.30
-116,971,821.21
-83,606,779.14
-97,234,030.67
Interest Income
3,184,505
3,184,505
6,732,269
1,611,541
1,282,545
Interest Expense
10,718,531
10,718,531
10,586,054
11,692,170
3,627,280
Net Interest Income
-7,534,026.11
-7,534,026.11
-3,938,784.30
-9,952,678.77
-2,263,104.05
EBIT
-98,530,609.85
-98,530,609.85
-202,210,260.22
-76,718,563.06
-106,822,150.20
EBITDA
-92,302,670.85
-92,302,670.85
-192,527,458.22
-60,392,913.06
-94,783,943.20
Reconciled Cost of Revenue
56,071,158.76
56,071,158.76
43,794,069.45
113,463,198.73
48,758,568.42
Reconciled Depreciation
6,227,939
6,227,939
9,682,802
16,325,650
12,038,207
Net Income from Continuing Operation Net Minority Interest
-91,980,166.74
-91,980,166.74
-187,546,646.85
-78,158,868.86
-98,125,465.67
Total Unusual Items Excluding Goodwill
21,848,843
21,848,843
-74,235,397
7,514,359
-1,188,580
Total Unusual Items
21,848,843
21,848,843
-74,235,397
7,514,359
-1,188,580
Normalized EBITDA
-114,151,513.85
-114,151,513.85
-118,292,061.22
-67,907,272.06
-93,595,363.20
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
244,457.44
244,457.44
-3,660,571.36
2,066,448.73
-297,145
12/31/2021 - 12/24/2008

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

115450.KQ HLB Therapeutics Co.,Ltd.
7,890.00
+1.02%
 
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0002
0.00%
 
1177.HK SINO BIOPHARM
3.910
+0.77%
 
UBX Unity Biotechnology, Inc.
0.9141
+0.46%
 
SGMT Sagimet Biosciences Inc.
3.2600
+1.87%
 
RANI Rani Therapeutics Holdings, Inc.
0.7300
-5.93%
 
CNTB Connect Biopharma Holdings Limited
0.8098
+1.23%
 
HRTX Heron Therapeutics, Inc.
2.1100
-2.76%
 
REGN Regeneron Pharmaceuticals, Inc.
527.78
-3.63%